Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019050893) HEPARIN COMPOSITION FOR TREATING ISCHEMIA
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/050893 International Application No.: PCT/US2018/049466
Publication Date: 14.03.2019 International Filing Date: 05.09.2018
IPC:
A61K 38/27 (2006.01) ,A61K 9/50 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
22
Hormones
27
Growth hormone (GH) (Somatotropin)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
48
Preparations in capsules, e.g. of gelatin, of chocolate
50
Microcapsules
Applicants:
EXCEL MED, LLC [US/US]; 108 Williamsburg Drive Starkville, MS 39759, US
NATIONAL CHENG KUNG UNIVERSITY; No. 1, Daxue Rd., East Dist. Tainan City 701, TW
Inventors:
HUANG, Lynn, L.H.; TW
Agent:
TSAO, Y., Rocky; US
Priority Data:
62/554,10105.09.2017US
Title (EN) HEPARIN COMPOSITION FOR TREATING ISCHEMIA
(FR) COMPOSITION D'HÉPARINE POUR LE TRAITEMENT DE L'ISCHÉMIE
Abstract:
(EN) A pharmaceutical composition for treating an ischemic tissue, comprising: a core component and a matrix component, wherein the core component includes a heparin or derivative thereof and the matrix component includes a hyaluronan or derivative thereof, the pharmaceutical composition having a viscosity greater than 10 mPa-s.
(FR) L'invention concerne une composition pharmaceutique pour le traitement d'un tissu ischémique, comportant : un composant principal et un composant matrice, le composant principal comprenant une héparine ou un dérivé de celle-ci, et le composant matrice comprenant un hyaluronane ou un dérivé de celui-ci, la composition pharmaceutique ayant une viscosité supérieure à 10 mPa-s.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)